Epitalon / Epithalon

Increase telomerase length. May help prevent or delay cognitive decline.

25% Lifespan Increase in Rats

The FDA is meeting with the Pharmacy Compounding Advisory Committee (PCAC) on 7/24/26 to evaluate Epitalon for insomnia.

Professor Vladimir Dilman and Dr. Ward Dean had co-authored a paper where it was noted by Dilman that in rats, the epithalamine biopeptide increased the lifespan by twenty-five per cent. The paper was entitled The Neuroendocrine Theory of Aging and Degenerative Disease. These Epithalon (Epitalon) studies were later confirmed by Russian Academy Sciences in Moscow Professor Vladimir Khavinson.

Cellular Regeneration

This peptide was discovered that causes telomerase production reactivation in the cells, which allows telomerase to become repaired. This results in the body’s rejuvenation down to the cellular level of your genes. The effects of pineal gland secretion are simulated by this simple tetrapeptide, thus activating the telomerase production in cells.

Senile and Elderly Individuals

The research done by Professor Khavinson was done on senile and elderly individuals that indicated mortality was reduced by almost half when this peptide was administered.

Predictive of Mortality

In elderly subjects, there have been established links between the shortening of a telomere and early mortality. This is how telomeres are considered synonymous to a human being’s biological clock. As these shorten progressively through continuous division of cells, they signal the onset of aging and death, ultimately. It the production of telomeres can be stimulated, cells in the body would not have a limit of time and would then continuously renew and replicate, slowing down the aging effects as a result.

EPITHALON (Epitalon) Effect on Life Span

Research studies prove that telomere lengths actually increase after the administration of the Epithalon (Epitalon) peptide on research subjects. After twelve years of Epithalon (Epitalon) peptide administration, the studies done by scientists proved a thirty to fifty per cent life span increase compared to those that did not receive EPITHALON (Epitalon). This translates to about seven extra years of excellent health and living. Clinical studies only lasted for twelve years and this produced seven extra years.

Cancer Research

Lifelong dosing in mice cut leukemia development by 6-fold. https://pubmed.ncbi.nlm.nih.gov/14501183/. And in HER-2/neu mice, Epitalon reduced tumor number, tumor size, and lung metastasis. https://pubmed.ncbi.nlm.nih.gov/12209581/

Dosage: 5-10mg per day, 5 days per week, 2 to 3 weeks per cycle, two or three cycles per year. Any time.
50mg vial with 2cc BAC, 20 units daily = 5mg per dose.
10mg vial with 2cc BAC, 40 units = 2mg